[go: up one dir, main page]

BRPI0812750A2 - Medicamento compreendendo uma combinação de substância ativa para tratamento de sintomas de alergia - Google Patents

Medicamento compreendendo uma combinação de substância ativa para tratamento de sintomas de alergia

Info

Publication number
BRPI0812750A2
BRPI0812750A2 BRPI0812750-6A2A BRPI0812750A BRPI0812750A2 BR PI0812750 A2 BRPI0812750 A2 BR PI0812750A2 BR PI0812750 A BRPI0812750 A BR PI0812750A BR PI0812750 A2 BRPI0812750 A2 BR PI0812750A2
Authority
BR
Brazil
Prior art keywords
understanding
treatment
active substance
substance combination
allergy symptoms
Prior art date
Application number
BRPI0812750-6A2A
Other languages
English (en)
Portuguese (pt)
Inventor
Marianne Petersen-Braun
Sabine Rabini
Sabine Glaeser
Klaus Kluthe
Original Assignee
Bayer Consumer Care Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Consumer Care Ag filed Critical Bayer Consumer Care Ag
Publication of BRPI0812750A2 publication Critical patent/BRPI0812750A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI0812750-6A2A 2007-06-08 2008-06-07 Medicamento compreendendo uma combinação de substância ativa para tratamento de sintomas de alergia BRPI0812750A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07011305 2007-06-08
PCT/EP2008/004567 WO2008148573A2 (fr) 2007-06-08 2008-06-07 Médicaments contenant une combinaison de principes actifs pour traiter les symptomes allergiques

Publications (1)

Publication Number Publication Date
BRPI0812750A2 true BRPI0812750A2 (pt) 2014-12-23

Family

ID=39926674

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0812750-6A2A BRPI0812750A2 (pt) 2007-06-08 2008-06-07 Medicamento compreendendo uma combinação de substância ativa para tratamento de sintomas de alergia

Country Status (4)

Country Link
EP (1) EP2164481A2 (fr)
BR (1) BRPI0812750A2 (fr)
RU (1) RU2472499C2 (fr)
WO (1) WO2008148573A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010260808A (ja) * 2009-05-01 2010-11-18 Ikeda Mohando:Kk 肌状態改善用経口医薬組成物
US11224618B2 (en) * 2012-04-16 2022-01-18 Zemtsov Enterprises, Llc Formulations and methods for treatment of acne and inflammatory skin conditions
RU2542448C1 (ru) * 2013-10-15 2015-02-20 Открытое акционерное общество "Московское производственное химико-фармацевтическое объединение им. Н.А. Семашко" Фармацевтическая композиция в виде пенного аэрозоля, обладающая противовоспалительным, регенерационным и антимикробным действием, и способ ее получения
MX2017001812A (es) * 2014-08-08 2017-07-17 Shenzhen Hightide Biopharmaceutical Ltd Composiciones de formulacion liquida, aparatos de administracion de medicamentos, y metodos de preparacion y uso de los mismos.
RU2605617C1 (ru) * 2015-06-25 2016-12-27 государственное автономное научное учреждение "Институт стратегических исследований Республики Башкортостан " Композиция для назального средства
ES2653787B1 (es) * 2016-07-07 2018-09-25 Diater Laboratorio De Diagnóstico Y Aplicaciones Terapéuticas, S.A. Composiciones de ácido cromoglícico para el tratamiento de la dermatitis
RU2646494C1 (ru) * 2017-07-05 2018-03-05 Общество с ограниченной ответственностью "НАТУРА СИБЕРИКА" (сокращенно ООО "НАТУРА СИБЕРИКА") Косметическая композиция против воспалений на коже для использования в составе косметических средств
UA122811C2 (uk) 2018-08-10 2021-01-06 Наталія Миколаївна Тихонівська Фармацевтична композиція
CN111388673A (zh) * 2020-03-22 2020-07-10 华中科技大学同济医学院附属协和医院 一种抗过敏外用凝胶膜及其制备方法
EP4566595A1 (fr) * 2023-12-07 2025-06-11 Bernhard Roth Preparation combinee pour le traitement de la rhinosinusite aigue et chronique

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2841527A (en) * 1955-11-07 1958-07-01 Us Vitamin Corp Medicinal emulsions
PL200231B1 (pl) * 1999-09-15 2008-12-31 Bayer Consumer Care Ag Środek farmaceutyczny i/lub kosmetyczny zawierający kwas pantotenowy i/lub jego pochodne oraz zastosowanie mieszaniny kwasu pantotenowego i/lub jego pochodnych
US20040247686A1 (en) * 2003-04-04 2004-12-09 Boehringer Ingelheim International Gmbh Pharmaceutical compositions comprising epinastine for the treatment of skin diseases
JP5021155B2 (ja) * 2003-08-01 2012-09-05 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング エピナスチンと1種以上のさらなる抗−h1−ヒスタミン類との組合せを含む皮膚疾患治療用製薬組成物

Also Published As

Publication number Publication date
WO2008148573A3 (fr) 2009-05-07
EP2164481A2 (fr) 2010-03-24
WO2008148573A2 (fr) 2008-12-11
RU2009148577A (ru) 2011-07-20
RU2472499C2 (ru) 2013-01-20

Similar Documents

Publication Publication Date Title
BRPI0812750A2 (pt) Medicamento compreendendo uma combinação de substância ativa para tratamento de sintomas de alergia
BRPI0916862A2 (pt) compostos úteis para o tratamento de doenças degenerativas e inflamatórias
BRPI1015569A2 (pt) compostos úteis para o tratamento de doenças degenerativas e inflamatórias.
BRPI1012116A2 (pt) composição farmacêutica para o tratamento de doenças cardíacas
BRPI0919288A2 (pt) teriapia de combinação para tratamento de diabetes e condições relacionadas.
BRPI1014759A2 (pt) composto útil para o tratamento de doenças degenerativas e inflamatórias
PT2367561E (pt) Composições e métodos para o tratamento da doença celíaca
BRPI0814624A2 (pt) Tratamento de doença neurodegenerativa progresiva com ibudilaste
BRPI0810082A2 (pt) 3-imidazolil-indóis para o tratamento de doenças proliferativas
BR112012013260A2 (pt) dispositivo usado para o tratamento de rinite através de iluminação bioestimulativa
PT2523661T (pt) Inibidores de nkcc para o tratamento de autismo
EP2210599A4 (fr) Préparation de bandage à la lidocaïne
HUE045367T2 (hu) Kombinált terápia diabétesz kezelésére
BRPI0816712A2 (pt) terapia de intervalo para o tratamento de tinnitus
BR112012002578A2 (pt) composição para o tratamento da fibrose cística
BRPI0815551A2 (pt) Tratamento através de hucbc de doença beta-amiloide
BRPI0911577A2 (pt) derivados espiro-indol para o tratamento de doenças parasíticas.
PL2582366T3 (pl) Kombinacja farmaceutyczna do leczenia bólu
CO6801718A2 (es) Composición terapéutica para el tratamiento de glioblastoma
ES2399651T8 (es) Utilización de pasireotida para el tratamiento de la hipoglucemia hiperinsulenémica endógena
EP2387418A4 (fr) Traitement de la douleur
BRPI0912890A2 (pt) composição farmacêutica para o tratamento de ejaculação precoce
BRPI0924107A2 (pt) inibidores de hsp90 para tratamento terapêutico
BRPI0812034A2 (pt) Combinações de neramexano para o tratamento de distúrbios neurodegenerativos
BR112012000101A2 (pt) carboidratos medicinais para tratamento de condições respiratórias

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]